bpc 157 subq dosage injury healing BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved BPC-157 Dosage Guide: How Much
Description
Plasma MOTS-c itself is not yet widely available as a clinical laboratory test, though research assays exist
Just keep it sealed, dry, and away from light
It contains 0.9% (9 mg/mL) benzyl alcohol, which functions as a bacteriostatic preservative by inhibiting microbial growth in the vial
This is similar to having a pimple, what I call the zit effect
The protocol is flexible enough to serve both goals
